New England Has $9 Billion Worth of Reasons to Embrace the Pharmaceutical-Biotech Industry

SUGAR LAND--July 24, 2013--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--North America has nearly 1,300 active Pharmaceutical-Biotech capital and maintenance projects with a total investment value (TIV) of $57 billion. According to a recent analysis of Industrial Info's Pharmaceutical-Biotech Industry database, the New England region reigns in the top spot with a $9 billion slice of that spending. Other companies featured: Vertex Pharmaceuticals (NASDAQ:VRTX), Novartis (NYSE:NVS)